Canada: Huge merger creates pot giant ahead of legalization

May 14, 2018
With legalization looming in Canada, big pot producer Aurora has announced a mega-merger with rival MedReleaf

With the legalization of recreational marijuana looming in Canada, therapeutic producer Aurora said Monday it was acquiring rival MedReleaf Corp. in a huge deal set to create a giant company.

Aurora said it would pay Can$3.2 billion ($2.51 billion) as part of an all-stock deal that will leave Aurora shareholders with control of 61 percent of the resulting .

The new company will have a production capacity of 570 tonnes of cannabis a year, with nine greenhouse operations in Canada and two in Denmark, Aurora and MedReleaf said in a joint statement.

The merger comes amid surging interest in the country's nascent pot industry with legalization expected this summer.

Already in January, Aurora had spent more than Can$1 billion to purchase rival CanniMed.

The Canadian originally scheduled legalization for July 1, coinciding with the Canada Day weekend, but complications with new distribution and monitoring systems forced delays.

But last week Prime Minister Justin Trudeau told AFP that legalization would come this summer.

While provincial governments work to set up distribution channels—and prepare to share resulting tax windfalls with the federal government—companies linked to the cannabis business have seen a speculative bubble develop.

The capitalization of the three biggest Canadian producers on the Toronto Stock Exchange has exploded in recent months.

Aurora shares have more than tripled in value in the past year, to more than Can$4.6 billion.

Whether or when that bubble might burst is unclear.

But it illustrates the growing interest in this soft drug, seen increasingly as a fiscal boon to governments in Canada, as it has been in US states like California that have legalized pot use.

In another deal, one of Aurora's chief rivals, Canopy Growth, announced Monday its purchase of the 33 percent of the Tweed Joint Venture group that it did not already own for Can$374 million, and said it planned to list its shares on the New York Stock Exchange.

Explore further: Canadian cannabis firms agree to merge to create pot giant

Related Stories

Canadian cannabis firms agree to merge to create pot giant

January 24, 2018
Canadian cannabis grower and seller Aurora Cannabis announced Wednesday a friendly acquisition of CanniMed Therapeutics in a deal valued at an estimated Can$1.1 billion (US$890 million) to create a global pot behemoth.

Canadian cannabis firm licensed to produce in Denmark

December 19, 2017
Canadian medical marijuana producer Canopy Growth said Monday its joint venture Spectrum Cannabis has been licensed to grow pot in Denmark for sale throughout the European Union.

Many dispensaries in CO proffer marijuana for morning sickness

May 11, 2018
(HealthDay)—More than two-thirds of Colorado cannabis dispensaries recommend cannabis products to treat nausea during the first trimester of pregnancy, according to a study published online May 7 in Obstetrics & Gynecology.

Recommended for you

Best of Last Year—The top Medical Xpress articles of 2017

December 20, 2017
It was a good year for medical research as a team at the German center for Neurodegenerative Diseases, Magdeburg, found that dancing can reverse the signs of aging in the brain. Any exercise helps, the team found, but dancing ...

Pickled in 'cognac', Chopin's heart gives up its secrets

November 26, 2017
The heart of Frederic Chopin, among the world's most cherished musical virtuosos, may finally have given up the cause of his untimely death.

Sugar industry withheld evidence of sucrose's health effects nearly 50 years ago

November 21, 2017
A U.S. sugar industry trade group appears to have pulled the plug on a study that was producing animal evidence linking sucrose to disease nearly 50 years ago, researchers argue in a paper publishing on November 21 in the ...

Female researchers pay more attention to sex and gender in medicine

November 7, 2017
When women participate in a medical research paper, that research is more likely to take into account the differences between the way men and women react to diseases and treatments, according to a new study by Stanford researchers.

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.